Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1581 (LINC01581) is a long intergenic non-coding RNA (lincRNA) gene, meaning it produces a non-protein-coding transcript longer than 200 nucleotides that is transcribed from a genomic region not overlapping with annotated protein-coding genes[1][3][5]. LincRNAs, including LINC01581, typically function in the regulation of gene expression at various levels, such as chromatin remodeling, transcriptional regulation, and stabilization of other RNA molecules[5][7]. Although some lincRNAs are implicated in disease processes, particularly in cancer and cell differentiation, there is no information available to suggest that LINC01581 itself is a direct therapeutic target, nor that it is associated with drug interactions, biomarker status, or specific disease roles in the current scientific literature[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1581 (LINC01581).